Sophia Genetics (SOPH) said Tuesday it entered into a partnership with biology firm Element Biosciences aiming to combine sequencing and AI analytics to streamline genomic workflows.
The collaboration will integrate Sophia Genetics' AI-powered analytics platform, Sophia DDM, with Element's AVITI24 5D multiomic and AVITI sequencing systems to deliver an end-to-end workflow for next-generation sequencing, the company said.
Shares of Sophia Genetics were 5.8% higher in premarket trading.